HuGE Literature Finder
Records 1-2
HFE C282Y mutation as a genetic modifier influencing disease susceptibility for chronic myeloproliferative disease.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009 Mar 18 (3): 929-34. Andrikovics Hajnalka, Meggyesi Nora, Szilvasi Aniko, Tamaska Julia, Halm Gabriella, Lueff Sandor, Nahajevszky Sarolta, Egyed Miklos, Varkonyi Judit, Mikala Gabor, Sipos Andrea, Kalasz Laszlo, Masszi Tamas, Tordai Atti |
HFE C282Y and H63D in adults with malignancies in a community medical oncology practice.
BMC cancer 2004 Feb 4 (): 6. Barton James C, Bertoli Luigi F, Acton Ronald |
- Page last reviewed:Oct 1, 2020
- Page last updated:Jan 15, 2021
- Content source: